Regeneron Pharmaceuticals
A Director-level role at Regeneron Genetics Center focused on cancer genetics and genomics, responsible for developing and executing strategies for cancer risk genomics product development, from clinical test development to commercialization. The role involves leading multidisciplinary teams and driving innovation in cancer genomics research and applications.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
33% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Laboratory Assistant II, Analytical and Biological Mass Spectrometry (ABMS)
Regeneron Pharmaceuticals
Post-Doctoral Researcher or Scientist
mountsinaihospital.com
Postdoctoral Fellow / Assistant Scientist
mountsinaihospital.com
Post-Doc Research Associate (Furey)
PeopleAdmin
Senior / Principal Scientist, Statistical Genetics
State of Indiana
Postdoctoral Research Associate, Cellular and Molecular Medicine
RYAN WHITE
Computational Scientist
The Translational Genomics Research Institute